Characterizing the network of drugs and their affected metabolic subpathways - Wikidata - wikimedia - TriplyDB

Characterizing the network of drugs and their affected metabolic subpathways

Characterizing the network of drugs and their affected metabolic subpathways

http://www.wikidata.org/entity/Q28484558

about

Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure.Identification of candidate drugs for the treatment of metastatic osteosarcoma through a subpathway analysis method.Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools.Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway A subpathway-based method of drug reposition for polycystic ovary syndrome.Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways.Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma.A sub-pathway based method to identify candidate drugs for glioblastomas.Drug repurposing a reality: from computers to the clinic.Cofunctional Subpathways Were Regulated by Transcription Factor with Common Motif, Common Family, or Common Tissue.Identification of potential drugs for Parkinson's disease based on a sub-pathway method.sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.Integrating gene and lncRNA expression to infer subpathway activity for tumor analyses.Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach.Pathway networks generated from human disease phenome

P2860

Q27144251-EF47968A-331F-43C3-9B64-9C9B6B9A494B Q33584126-4ED5244D-9215-48BC-A5F7-1863FD3C3FF6 Q33751305-18687755-EFC1-491E-A163-1C9935154531 Q34105263-97D64BAF-46FB-4F23-86A5-7C744FF7DAA5 Q35711258-5FB75676-68C6-4B4E-8B57-E118E4DE3E4C Q36742634-2942A733-AF8C-4269-A8CF-FFC34AF6BB36 Q36814160-FB8E7B78-9909-4546-98CF-290F88D532FE Q37254146-B9D93F18-79FD-4273-B0D1-0A5D0937E11C Q38944703-57E44651-3745-487D-AB88-D1B98E7CAB21 Q38963849-355D0BFB-5E45-410F-B9B5-6000B0098ED6 Q41479954-03596886-684A-4A3D-B013-8ECC283F877C Q42156758-8CBE93A7-066F-40E1-A210-8E9ACF7A4F74 Q42703601-8E6E14BA-E70E-45C2-8E23-9572C85C4679 Q45911404-615AF275-8B68-4B47-93FE-3358591033C1 Q48534828-D846B30F-D162-427E-A5AB-98D5D1834234 Q52344574-BFD10349-4C90-4F71-8F32-8BBBE81FE7AD Q54941802-1FDA9580-D102-4F97-89E4-22D8FD4F57F0 Q58739344-4BA026BA-2FEB-42C3-A0CC-66AAF48F60EA

P2860

Characterizing the network of drugs and their affected metabolic subpathways

http://www.wikidata.org/entity/Q28484558

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Characterizing the network of drugs and their affected metabolic subpathways

@ast

Characterizing the network of drugs and their affected metabolic subpathways

@en

Characterizing the network of drugs and their affected metabolic subpathways

@nl

type

label

Characterizing the network of drugs and their affected metabolic subpathways

@ast

Characterizing the network of drugs and their affected metabolic subpathways

@en

Characterizing the network of drugs and their affected metabolic subpathways

@nl

prefLabel

Characterizing the network of drugs and their affected metabolic subpathways

@ast

Characterizing the network of drugs and their affected metabolic subpathways

@en

Characterizing the network of drugs and their affected metabolic subpathways

@nl

P1433

Q28484558-F35288D7-E388-4C57-B2B5-D9CB234F4CD0

P1476

Q28484558-34428C49-04FD-421D-93B5-B65FB2BBD9BA

P2093

Q28484558-0BE6FA4B-D084-42E6-BF9E-6DF354CB39F8

Q28484558-13CF7B20-80AD-44A3-AC78-C267502255B4

Q28484558-1E739788-12CE-4923-93FC-A96C417B7192

Q28484558-348EE4FB-70E2-48D0-971E-A78034D53F9D

Q28484558-43CADC2C-04D9-41C7-91E8-55AEEE4017F4

Q28484558-75F32A2D-BA4A-4631-8EBF-001ABF1993A2

Q28484558-A6585A22-9247-49D6-AE68-B9A63FBAA9FE

Q28484558-B1806842-CCBE-47CE-AB1A-C64178BEDC96

Q28484558-B82770AA-C024-4F99-A37F-CA8CF9A92BD7

Q28484558-BF9C5C1A-8E4C-4A82-A961-891456481070

P2860

Q28484558-021C0A94-5F3D-471B-998A-3E5D386A70EF

Q28484558-0242C60B-4806-496E-ADD4-C61F5893BC3B

Q28484558-02F2A334-6B06-4F13-84BA-DD115FFC679F

Q28484558-082A5163-A39C-429F-B8E1-448B2B6066B2

Q28484558-0A250878-8FE8-43B0-A998-241E554F61B0

Q28484558-0AD67433-292D-4364-A7D1-3C6C8F1EC05E

Q28484558-0C0531D1-F106-43D1-936F-262429BE8F21

Q28484558-11BF62D0-B1A7-464E-A7CB-F5936F8EAFAC

Q28484558-12CA2877-4E0E-41E9-A948-540B9E8E9AA7

Q28484558-12D17DBB-00CD-4717-8159-9DD8EE8D0C5E

P304

Q28484558-BA3824D3-CB7E-4CE4-81E6-09F23F37DB07

P31

Q28484558-C50B1D60-58C8-4FEF-AA39-D4B6C92C79E3

P3181

Q28484558-A6337948-AA73-485A-BA45-3D2F9D5E41C1

P356

Q28484558-515EDC8A-6A55-448A-84B9-2A2E6EDB2821

P407

Q28484558-65AB0EE5-9B31-4AB4-A06B-0BC93D7624D2

P433

Q28484558-677FDCDD-5E35-49C2-AA9C-54D600514E96

P478

Q28484558-1ACD3798-B62B-444F-9DF9-2F62EF78ECFC

P577

Q28484558-06391C37-A662-4EBB-8C80-3A04063ED925

P5875

Q28484558-9E63EE81-6D42-424C-AC57-F3A2696E812A

P698

Q28484558-6A47520A-0190-4A2C-B11A-22A9AF581F48

P932

Q28484558-027AFAC2-9B89-4DDC-9D8C-91A5988292B3

P3181

P356

JOURNAL.PONE.0047326

P1433

P1476

Characterizing the network of drugs and their affected metabolic subpathways

@en

P2093

Chunlong Zhang

http://www.w3.org/2001/XMLSchema#string

Chunquan Li

http://www.w3.org/2001/XMLSchema#string

Desi Shang

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Junwei Han

http://www.w3.org/2001/XMLSchema#string

Qianlan Yao

http://www.w3.org/2001/XMLSchema#string

Shuyuan Wang

http://www.w3.org/2001/XMLSchema#string

Wei Jiang

http://www.w3.org/2001/XMLSchema#string

Xia Li

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

From genomics to chemical genomics: new developments in KEGG

Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate

DrugBank: a knowledgebase for drugs, drug actions and drug targets

The human disease network

Network biology: understanding the cell's functional organization

Drug discovery: Predicting promiscuity

Network pharmacology: the next paradigm in drug discovery

Human disease-drug network based on genomic expression profiles

A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib

Modularity in protein complex and drug interactions reveals new polypharmacological properties

P304

e47326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3535737

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0047326

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232742557

http://www.w3.org/2001/XMLSchema#string

P698

23112813

http://www.w3.org/2001/XMLSchema#string

P932

3480395

http://www.w3.org/2001/XMLSchema#string